Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 06, 2015 9:44 PM ET

Biotechnology

Company Overview of Predictive Biomarker Sciences, Inc.

Executive Profile

Andrew R. Allen BM, BCh, MA, MRCP, Ph.D.

Co-Founder, Chief Medical Officer and Executive Vice President of Clinical & Pre-Clinical Development, Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
47$1,668,945
As of Fiscal Year 2013

Background

Dr. Andrew R. Allen, M.D., Ph.D., co-founded Clovis Oncology, Inc., on April 20, 2009 and has been its Chief Medical officer and Executive Vice President of Clinical & Pre-Clinical Development since April 20, 2009. Dr. Allen served as the Chief Medical Officer of Pharmion Corp., since May 18, 2006 and served as its Executive Vice President since August 2006. He served as a Vice President of BioPharma Development and Head of the Oncology Therapeutic Unit for Chiron. At ...

Corporate Headquarters

2036 East Hackamore Street
Mesa, Arizona 85213

United States

Phone: 602-418-9300
Fax: 480-247-5493

Board Members Memberships

Former Director
2014-Present
Director and Member of Audit Committee

Education

Master's Degree
The Royal College of Physicians
Unknown/Other Education
University of Oxford
PhD
Imperial College

Other Affiliations

Annual Compensation

Salary$396,167
Bonus$238,860
Total Annual Compensation$635,027

Stocks Options

All Other Compensation$15,485
Exercisable Options$69,287
Exercisable Options Value$3,479,229
Unexercisable Options$124,678
Unexercisable Options Value$5,112,087
Total Value of Options$8,591,315
Total Number of Options$193,965

Total Compensation

Total Annual Cash Compensation$650,512
Total Short Term Compensation$635,027
Other Long Term Compensation$15,485
Total Calculated Compensation$1,668,945
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Predictive Biomarker Sciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.